Skip to main content
. 2023 May 18;9(7):919–927. doi: 10.1001/jamaoncol.2023.0990

Figure 2. Kaplan-Meier Curves for Progression-Free Survival Based on MGMT Promoter Methylation Status.

Figure 2.

A, Patients who received chemotherapy. B, Patients with IDH–wild type tumors. C, Patients with IDH–mutant and non-codeleted tumors. D, Patients with IDH–mutant and codeleted tumors.